News
Building a better future for women’s health: The role of digital innovation
The landscape of women’s health is undergoing a remarkable transformation, driven by digital innovation.
This shift is more than just a technological upgrade; it’s a profound change that promises better healthcare outcomes, enhanced accessibility, and personalised treatment options for women everywhere.
From mobile health apps to telemedicine, digital tools are bridging gaps in healthcare and offering new ways to monitor, diagnose, and treat health conditions.
These innovations are particularly significant in women’s health, where specific needs have often been overlooked or underfunded.
Now, with the power of technology, we are witnessing a surge in solutions tailored to women’s health issues, making healthcare more inclusive and effective.
Empowering Women Through Health Apps
Health apps are revolutionising how women manage their health. These digital platforms offer everything from menstrual cycle tracking to pregnancy monitoring and mental health support.
With the ease of smartphone access, women can now track their health data in real-time, identify patterns, and make informed decisions about their well-being.
These apps also foster community and support networks.
Women can connect with others facing similar health issues, share experiences, and receive advice, creating a supportive environment that extends beyond traditional medical settings.
Telemedicine: Breaking Barriers
Telemedicine has emerged as a powerful tool in women’s health, particularly for those in remote or underserved areas.
By enabling virtual consultations, telemedicine eliminates the need for travel, making it easier for women to access healthcare professionals.
This convenience is especially beneficial for those with busy schedules or mobility issues.
Telemedicine offers a level of privacy and comfort that traditional in-person visits may not.
Women can discuss sensitive health issues from the privacy of their homes, leading to more open and honest communication with healthcare providers.
Wearable Technology: Monitoring Health on the Go
Wearable technology is another game-changer in women’s health.
Devices like fitness trackers and smartwatches now come equipped with features that monitor vital signs, track physical activity, and even offer menstrual cycle predictions.
By integrating wearable technology with health apps, women can have a comprehensive view of their health.
This integration allows for better tracking of symptoms and more personalised healthcare plans, ultimately leading to improved health outcomes.
Artificial Intelligence in Women’s Health
Artificial Intelligence (AI) is playing a crucial role in advancing women’s health.
AI algorithms can analyse vast amounts of health data to identify patterns and predict potential health issues.
For instance, AI is being used to improve breast cancer detection by analysing mammograms more accurately than traditional methods.
AI also enhances personalised medicine by tailoring treatments to individual needs.
By considering genetic, environmental, and lifestyle factors, AI can help healthcare providers develop more effective treatment plans.
Spreading Awareness with Digital Publications
Creating awareness about women’s health is essential, and digital magazine makers are pivotal in this effort.
These platforms allow the creation of interactive magazines that engage readers with rich multimedia content, making health information more accessible and engaging.
Interactive magazines can cover a wide range of topics, from reproductive health to mental wellness, providing valuable insights and practical advice.
By leveraging digital formats, these magazines can reach a broader audience, ensuring that more women are informed about their health options and empowered to make better decisions.
Genomics and Personalised Medicine
Genomics is opening new doors in personalised medicine for women.
By studying a person’s genetic makeup, healthcare providers can predict the risk of certain diseases and tailor prevention strategies accordingly.
This approach is particularly beneficial in women’s health, where conditions like breast and ovarian cancer have strong genetic links.
Personalised medicine goes beyond genetics, considering individual lifestyles and environments.
This holistic approach ensures that treatments are more effective and side effects are minimised. For women, this means more accurate diagnoses and targeted therapies, leading to better health outcomes.
Mental Health: Digital Therapies and Support
Digital innovation is also transforming mental health care for women. Online therapy platforms and mental health apps provide accessible and affordable support for various mental health issues, from anxiety to postpartum depression.
Women can access therapy from the comfort of their homes, at times that suit their schedules.
This flexibility encourages more women to seek help and maintain consistent mental health support. Digital platforms often provide anonymity, which can reduce the stigma associated with seeking mental health care.
Reproductive Health: Enhancing Fertility and Pregnancy Care
Reproductive health is a critical area where digital innovation is making a significant impact.
Fertility apps and telemedicine consultations offer new ways for women to monitor their reproductive health, track ovulation cycles, and receive expert advice on conception and pregnancy.
Pregnancy care has also benefited from digital tools.
Expecting mothers can use apps to track their pregnancy progress, access educational resources, and connect with healthcare providers for virtual check-ups.
Chronic Disease Management
Managing chronic diseases like diabetes and hypertension is challenging, but digital tools are making it easier.
Health apps and wearable devices help women monitor their conditions, track medication adherence, and maintain healthy lifestyles.
Digital platforms also facilitate better communication between patients and healthcare providers.
Women can share their health data with doctors in real-time, allowing for timely adjustments to treatment plans.
Educating the Next Generation
Digital innovation is also playing a crucial role in educating the next generation about women’s health.
Interactive platforms and online courses provide young women with accurate and comprehensive health information.
These resources cover topics like menstrual health, sexual education, and mental well-being.
By making health education engaging and accessible, digital tools empower young women to take charge of their health from an early age.
This early intervention helps establish healthy habits and awareness, leading to better health outcomes in the long term.
The Future of Women’s Health
The future of women’s health looks promising with ongoing digital innovation. Emerging technologies like virtual reality and advanced AI are set to revolutionise healthcare further.
These innovations will continue to enhance the quality and accessibility of healthcare for women, addressing their unique needs more effectively.
As technology continues to evolve, the potential for improving women’s health outcomes grows.
By embracing these digital tools, women can look forward to a future where healthcare is more personalised, efficient, and supportive, ensuring better health and well-being for all.
Menstrual Health: Tracking and Insights
Digital tools are revolutionising menstrual health management.
Period tracking apps enable women to log their cycles, predict ovulation, and monitor symptoms, providing valuable insights into their reproductive health.
These apps offer personalised reminders for cycle-related activities, such as taking medications or scheduling doctor appointments.
Additionally, menstrual tracking apps often include educational content about menstrual health and wellness.
This information empowers women to understand their bodies better, identify irregularities early, and seek medical advice when necessary.
Nutrition and Fitness: Personalised Plans
Maintaining a healthy lifestyle is vital for women’s health, and digital innovation is making it easier to achieve.
Nutrition and fitness apps provide personalised meal plans and exercise routines tailored to individual needs and goals.
These apps consider factors like dietary preferences, fitness levels, and health conditions to create customised plans that are both effective and sustainable.
These apps offer features like calorie tracking, nutrient analysis, and workout tutorials, making it simple for women to stay on top of their health and fitness goals.
By integrating these tools into daily routines, women can improve their physical health, boost energy levels, and enhance overall quality of life.
Summary
Digital innovation is not just a trend but a crucial component in advancing women’s health.
From health apps to AI-driven diagnostics, these technologies offer new opportunities for better health management and improved outcomes.
The future holds exciting possibilities for women’s health, with digital innovation at the forefront.
Embracing these advancements ensures a more inclusive and effective healthcare system, where women receive the care and attention they deserve.
Ovarian cancer cells quickly activate survival responses after PARP inhibitor treatment, and a lung cancer drug could help block this, research suggests.
PARP inhibitors are a common treatment for ovarian cancer, particularly in tumours with faulty DNA repair. They stop cancer cells fixing DNA damage, which leads to cell death, but many tumours later stop responding.
Researchers identified a way cancer cells may survive PARP inhibitor treatment from the outset, pointing to a potential way to block that response. A Mayo Clinic team found ovarian cancer cells rapidly switch on a pro-survival programme after exposure to PARP inhibitors. A key driver is FRA1, a transcription factor (a protein that turns genes on and off) that helps cancer cells adapt and avoid death.
The team then tested whether brigatinib, a drug approved for certain lung cancers, could block this response and boost the effect of PARP inhibitors. Brigatinib was chosen because it inhibits multiple signalling pathways involved in cancer cell survival.
In laboratory studies, combining brigatinib with a PARP inhibitor was more effective than either treatment alone. Notably, the effect was seen in cancer cells but not normal cells, suggesting a more targeted approach.
Brigatinib also appeared to act in an unexpected way. Rather than working through the usual DNA repair routes, it shut down two signalling molecules, FAK and EPHA2, that aggressive ovarian cancer cells rely on. FAK and EPHA2 are proteins that relay survival signals inside cells. Blocking both at once weakened the cells’ ability to adapt and resist treatment, making them more vulnerable to PARP inhibitors.
Tumours with higher levels of FAK and EPHA2 responded better to the drug combination. Other data link high levels of these molecules to more aggressive disease, pointing to potential benefit in harder-to-treat cases.
Arun Kanakkanthara, an oncology investigator at Mayo Clinic and a senior author of the study, said: “This work shows that drug resistance does not always emerge slowly over time; cancer cells can activate survival programmes very early after treatment begins.”
John Weroha, a medical oncologist at Mayo Clinic and a senior author of the study, said: “From a clinical perspective, resistance remains one of the biggest challenges in treating ovarian cancer. By combining mechanistic insights from Dr Kanakkanthara’s laboratory with my clinical experience, this preclinical work supports the strategy of targeting resistance early, before it has a chance to take hold. This strategy could improve patient outcomes.”
Nighttime temperatures during pregnancy may be linked to a higher chance of an autism diagnosis in children, a recent study suggests.
The research tracked nearly 295,000 mother-child pairs in Southern California from 2001 to 2014 and linked warmer overnight temperatures with higher risk in early and late pregnancy.
Children of mothers exposed to higher than typical nighttime temperatures during weeks one to 10 of pregnancy had a 15 per cent higher risk of an autism diagnosis.
Exposure during weeks 30 to 37 was linked to a 13 per cent higher risk.
Lead author David Luglio, a post-doctoral fellow at Tulane University, said: “A key takeaway is that we identified specific windows when a mother and her developing child can be most affected by exposures to higher nighttime temperatures.
“This is critical and hopefully can help mothers prepare accordingly.”
The study is described as the first to examine how temperature may affect fetal neurodevelopment, the process by which a baby’s brain and nervous system form during pregnancy.
Extreme temperatures linked to increased risk were classified as above the 90th percentile, meaning 3.6°F hotter than average, and the 99th percentile, 5.6°F above average.
The association held even after researchers accounted for factors such as neighbourhood conditions, vegetation and fine-particle air pollution.
The study could not account for other factors such as access to air conditioning. Researchers did not find the same association with daytime temperatures, potentially because people spend more time away from home during the day.
“Heat waves are becoming more frequent, and people may only think of the dangers of daytime heat exposure,” said Mostafijur Rahman, assistant professor of environmental health sciences at Tulane University.
“These results indicate a strong association between high nighttime temperatures during pregnancy and autism risk in children and show that we need to think about exposure to heat around the clock.”
The study did not examine how higher temperatures at night might affect prenatal development, though Luglio said it is possible that warmer nights disrupt sleep for pregnant mothers.
Previous research has suggested insufficient sleep during pregnancy may be linked to a higher risk of neurocognitive delays in children.
“Extreme heat exposure during pregnancy has been linked to a range of adverse health outcomes, including prenatal neurodevelopment delays and complications with an embryo’s development of a central nervous system,” Luglio said.
“The goal of our study was to specifically explore the link between prenatal heat exposure and autism diagnoses for the first time.”
Kindbody has launched a fertility platform integrating AI with clinical care and patient support for employers and health plans.
The platform will enter a pilot with select Kindbody employer clients in 2026, covering over three million lives, ahead of wider availability in 2027.
Building on the company’s clinical model, the platform aims to improve outcomes and cost efficiency across family-building journeys. It connects Kindbody-owned clinics, partner clinics and an integrated clinical app.
The app offers virtual care across conception, pregnancy and reproductive health, extending through the menopause transition.
Launch features include updates in medication management, third-party reproduction, adoption, pregnancy, men’s health and global programme design.
David Stern, chief executive of Kindbody, said: “With our next-generation fertility platform, Kindbody is redefining what comprehensive, intelligent and affordable family-building care looks like for employers, health plans and patients.
“By unifying best-in-class clinical care, AI-driven intelligence and whole-person support, we are making it easier and more cost-effective for more people to build the families they envision.”
Kindbody has expanded access via its national network of IVF centres, including IVIRMA, Inception Fertility and Ivy Fertility.
A new Fertility Medication Portal is designed to streamline authorisations so medicines can be dispensed on time, giving patients visibility from prescription to coverage, pharmacy fulfilment and delivery tracking.
Through KindMan, men’s health education, digital resources and integrated clinical care are expanding, including hormone management programmes.
Services cover andropause (age-related testosterone decline), erectile dysfunction, low testosterone and other male reproductive conditions.
Specialist fertility care includes semen analysis, diagnostic testing, male hormone panels, genetic testing, surgical sperm extraction and sperm cryopreservation.
Launching in the second quarter, a pregnancy support app will act as a digital companion for expecting and new parents, with resources, interactive tools and clinical assessments to identify social drivers of health and mental health needs during pregnancy and beyond.
Kindbody’s physician-led menopause programme provides consultations with board-certified obstetricians and gynaecologists to diagnose, treat and manage menopausal symptoms, including hormone replacement therapy where appropriate, with support from nutritionists, mental health therapists and pelvic floor specialists.
AI and analytics will be embedded across the care journey. An AI care navigator will guide employees from benefit activation through intake, triage and scheduling.
Tools will track benefits and treatment plans, showing coverage and expected out-of-pocket costs at each step.
AI-supported scribing will assist clinicians with documentation, and a predictor tool will estimate a patient’s likelihood of having a baby across different treatment paths.
In 2027, Kindbody plans a savings model for eligible large employers that it says will guarantee lower total fertility spend while improving clinical efficiency and patient experience.
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Wellness4 weeks agoChina’s birth rate hits record low despite government fertility efforts
-
Menopause3 weeks agoHRT linked to greater weight loss on tirzepatide
-
Entrepreneur5 days agoUS startup builds wearable hormone tracker
-
Menopause2 weeks agoFlo Health and Mayo Clinic publish global perimenopause awareness study
-
News4 weeks agoVerdane invest in Clue to accelerate the future of women’s health